Introduction The antibody-drug conjugate trastuzumab deruxtecan (T-DXd) targets human
epidermal growth factor receptor 2 (HER2) and has been evaluated in patients with HER2 …

Chemotherapy is one of the widely used anticancer treatments that involves the use of
powerful cytotoxic drugs to stop tumor growth by targeting rapidly dividing cells through …

Simple Summary This article provides an overview of supportive care in cancer, a service
that supports people living with and beyond cancer through the prevention and …

The origins of the major classes of current anti-emetics are examined. Serendipity is a
recurrent theme in discovery of their anti-emetic properties and repurposing from one …

Abstract Background Intragastric balloons (IGBs) are a minimally invasive option for obesity
treatment, acting as a space-occupying device and leading to weight loss through increased …

Background Gastrointestinal symptoms are common in patients with cancer, whether related
to treatment or a direct effect of the disease itself. Patients may choose to access …

1. Anti-SARS-CoV spike antibodies promote infection of primary human immune cells by
SARS-CoV. 2. The antibody-dependent enhancement (ADE) infection pathway grants SARS …

Nausea and vomiting are still considered to be two of the most troublesome adverse events
(AEs) for patients treated with antineoplastic therapy. To optimise the utility of available …

Purpose This systematic review updates the MASCC/ESMO recommendations for high-
emetic-risk chemotherapy (HEC) published in 2016–2017. HEC still includes cisplatin …

PURPOSE To guide clinicians, adults with cancer, caregivers, researchers, and oncology
institutions on the medical use of cannabis and cannabinoids, including synthetic …